Eight patients with the Gait Ataxia Downbeat Nystagmus Syndrome, aged 56–73 years (mean ± SD = 68 ± 7 years, female = 5/8 (62.5%)), were recruited. Twelve healthy controls matched closely in age and gender, aged 51-75yrs (mean ± SD = 64 ± 6 years, female = 7/12 (58.3%); no significant between-group difference in age (t(17) = 1.35, p = .195)), were also tested. All controls were in good health with no history of neurological illness.
All patients underwent neurological examination by an experienced neurologist (AMB) to confirm downbeat nystagmus and gait ataxia but no upper limb ataxia, thus implicating vestibulo-cerebellar (flocculo-nodular-parafloccular) damage (Zee et al.
1976; Pierrot-Deseilligny and Milea
2005; Patel and Zee
2014). The nystagmus was seen by naked eye in all cases, enhancing on convergence, lateral gaze, head shaking and positional manoeuvres, typical for this syndrome (Wagner et al.
2008). The Gait Ataxia Downbeat Nystagmus Syndrome is caused by dysfunction of the vestibulo-cerebellum and is selectively reproduced in monkeys by flocculectomy (Zee et al.
1981). It is associated with pathology in the cranio-cervical junction (Bronstein et al.
1987) and functional imaging demonstrates changes in the cerebellar tonsils, flocculus and paraflocculus bilaterally (Dieterich and Brandt
2008). In our patients, the main aetiology was idiopathic (
n = 7), with one patient with familial downbeat nystagmus, gait instability and a SCA6 phenotype, but who did not wish to undertake genetic testing. MRI scans were reported by consultant neuroradiologists as vermal atrophy (
n = 2), superior cerebellar atrophy (
n = 1), flocculo-nodular atrophy (
n = 2) and within normal limits for age in the rest (
n = 3). Gait ataxia Downbeat Nystagmus Syndrome is a well-defined and fairly homogenous albeit rare neurological syndrome, diagnosed in around only 2% of patients seen per year in highly specialised balance centres (Wagner et al.
2008). Given the nature of our task, patients with major gait disorder had to be excluded. The number of participants recruited (
n = 8) is comparable to previous research investigating gait adaptation (which used
n = 9 (Morton and Bastian
2006) and reaching adaptation (which used
n = 7 or
n = 9 (Tseng et al.
2007; Schlerf and Ivry
2011)) in patients with cerebellar damage.
Prior to testing, all participants completed an overground walking assessment (modified version of the equilibrium coordination test used to assess gait ataxia severity (Armutlu et al.
2001)) as an evaluation of gait ataxia. Participants were instructed to walk as fast as they comfortably could over 3 m whilst keeping their feet between two parallel lines placed 20 cm apart. Participants were timed as they walked up and down continuously three times. On average, the CBL participants stepped out of the designated walkway with 51.1% of their steps (SD = 16.1%, range = 35.0–68.3%) compared to the controls who only placed 2.2% (SD = 3.8%, range = 0–11.8%, 9/12 scoring 0%) of steps outside the designated lines (Z = -3.66,
p < .001). Additionally, the patients took on average 22 ± 12 s to complete the task, whereas the controls only took 10 ± 2 s (Z = -3.56,
p < .001).
The experimental procedure was approved by the Imperial College London ethics committee, and informed consent was obtained for all participants. Data collection took place in the Balance Lab at Charing Cross Hospital, London UK.